9999999997-13-012397.txt : 20130802 9999999997-13-012397.hdr.sgml : 20130802 20130802111416 ACCESSION NUMBER: 9999999997-13-012397 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130802 DATE AS OF CHANGE: 20130802 20130802 20130802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 131005246 BUSINESS ADDRESS: STREET 1: 9815 S. MONROE STREET STREET 2: SUITE 100 CITY: SANDY STATE: UT ZIP: 84070 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 9815 S. MONROE STREET STREET 2: SUITE 100 CITY: SANDY STATE: UT ZIP: 84070 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.)094P`C$+`P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9II-JLR++FQG)]-&LQV-+_[*$'ZIHM;W,@9%TTGVF&CSG=[@SHIN=$>&G$FR*Q0NQ:"T"F<3NOC:A1% M,8P"^R!NV3:%B[5#9ZK,BZ=W65[J%A;Z)]S7I:K>.VRA2DT<8@$77Z:C:5UL MYYG#4]-HL]F31=V4JG"A!R])6D6?C"KRS:3:%1HH28TNO]K_6?CW(1^A4M1HYS[6_K3;U-J]VY"&O)E6;G[]G>=.:Z[UJ(.`777#0.*3/ MJF,P)DGZ^-V@H*QYU$[969XMO37[=L4C"K@BZL_A0BP(`O`<9/QK_ZV&Y+S[ MQ2V$!,$82!F['<2)8V$\"4//D_$Y,XJ$PT[YIWK]NNP;VBJHV$=X5\N?6,UI MC<2):?L[=B36;S6@^-V`5+[.@/_U7OB,]V+^-NN]UG6<7KB.\Q>XKE\X!]PO M\UU_.\UZZ#SGM\X_Z#L_>7KN@[&X\V"?X5F]Y_YIL+0B1=WVS>O861<;![65HL"F*&2+MEG(DE>7 M9MVO[_"B^!(G#F)2(CESYLR9H3_=+PELF\&7=/`I32D02#<#0L'#/QP2#R(O M=F,&Z7[@P1;_T[7\>AE88*?_#$@,#G%)`.F=>9/^:B:.[R;):=5Q/8\D\KB9 MO`R^6T_S63JQ'>8FUATL;2=P(RNU76*-4OUV8EZ"_5?ZV\`)W2@*+FUZH;$I M)]+F(:&Q\7=9`'WMA-C MZ(O1/)W-[Q'=?*I@$>HRAOGH3U-S.J#Z].QN@B=&WR!=3$;I`SX8MO!@&)PA M,X=!`>8 MZZQ7DLK0;>".Y6'2\^R@7+4`.5$ M`G0DD@#%):GS)5Y"4,"_2-R!19,(X^[%'`>WV?S[UJ='8:#*[)I:8"<*O&7O!.9NP`$9;0=*N]'2-VT;8\5R\A*R$['`JQUAGLRIS7L.@* M#I2M'`HU_]'QIA7E5@>'74"6N:_)H6&D_:^KZZ')=+(GK]2D\*Q::$(V`Y["I*XS/ M@G;'8?)S)U:B;:"M((-I5:L5XCF_PT84N-E4DK9Z*U>(X"$[0J);PA"9RB'; M!E9'..5/X:.> M&YP'S7J3IF@NRZ_=92U^B4:RJB+&$C>5J:(UYFYU0AI[AL@?75:(C>`-9`W( MO)J4%OBPW]L1:I[7:_EB#(KU8$WL+3<9+ZF->=YI=>@ MVO3I49;/E$_ZR&?7ID;K=@@!/+E+=^Q"$-!G:_5L/UOLV1XJ#W?B7Z'A8@FP M,[SF*B#,-.U&FD,(Y]1.50P<=LA)SEM>[T5Y$I$V>%&@ND!HPDR!E%4KI7CH M5EAKQ1%RT:R+JN&H4L&NIHRTCI./0%`8BZ"DU+,@24-%N MJJ*H7E[+UM$F;^F<]Y7R(HH"),X51VD67,D4,4MSZA;`>S^ZHLUYO4*_6SHV M]*PSV@HIED1V26^QJT^DT+\EZUXNS.4/KC]I*L/N^/Y M;:5_2:H4LG,32[ZN>9O51[RB0NOUQ+O0)NG@?P$&`'C#U&H-"F5N9'-T,E,P4#!7 M,+10L+'1]RO-+8X&<0T4@F+M[(`BP?HN=G8``08`C84(-PT*96YDFMC.60B/SX*/'@Z>&UP;65T82!X;6QN M#IX;7!T:STB061O8F4@6$U0($-O&UL;G,Z M9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O M9G0@5V]R9"`M(#(Y-S0S+D]21$52/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO M&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D M9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0&UP34TZ26YS=&%N8V5) M1#YU=6ED.C`V.30Y9C`W+3@Q-#DM-#1F,"UA-#@S+3@Y.3DU9#@P-CDW,3PO M>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@ M(#POJ'5!:DZ@7!E+UA2968O5ULQ(#(@,5T^/G-T